| Low aAIP | High aAIP | ||||
---|---|---|---|---|---|---|
N | OR (95%CI) | P | N | OR (95%CI) | P | |
CAD risk | ||||||
 Sex | 369 |  |  | 368 |  |  |
  Female | 185 | Reference |  | 140 | Reference |  |
  Male | 184 | 1.089(0.538-2.202) | 0.813 | 228 | 8.904(3.463-22.898) | <0.001 |
 HbA1c | 369 |  |  | 368 |  |  |
  <7.5 | 246 | Reference |  | 191 | Reference |  |
   ≥ 7.5 | 123 | 1.303(0.748-2.268) | 0.349 | 177 | 1.361(0.741-2.500) | 0.320 |
 Age | 369 |  |  | 368 |  |  |
  <65 | 192 | Reference |  | 242 | Reference |  |
   ≥ 65 | 177 | 1.457(0.775-2.738) | 0.243 | 126 | 0.639(0.304-1.345) | 0.238 |
 Antidiabetic/or insulin | 369 |  |  | 368 |  |  |
  No | 122 | Reference |  | 129 | Reference |  |
  Yes | 247 | 1.214(0.691-2.131) | 0.501 | 239 | 0.781(0.420-1.453) | 0.436 |
Muti-vessel lesion risk | ||||||
 Sex | 369 |  |  | 368 |  |  |
  Female | 185 | Reference |  | 140 | Reference |  |
  Male | 184 | 2.254(1.127-4.509) | 0.022 | 228 | 5.454(2.613-11.388) | <0.001 |
 HbA1c | 369 |  |  | 368 |  |  |
  <7.5 | 246 | Reference |  | 191 | Reference |  |
   ≥ 7.5 | 123 | 1.237(0.725-2.112) | 0.436 | 177 | 1.281(0.804-2.042) | 0.298 |
 Age | 369 |  |  | 368 |  |  |
  <65 | 192 | Reference |  | 242 | Reference |  |
   ≥ 65 | 177 | 1.750(0.952-3.215) | 0.071 | 126 | 1.272(0.730-2.217) | 0.395 |
 Antidiabetic/or insulin | 369 |  |  | 368 |  |  |
  No | 122 | Reference |  | 129 | Reference |  |
  Yes | 247 | 1.176(0.672-2.059) | 0.569 | 239 | 1.075(0.664-1.741) | 0.769 |